Association of endothelial nitric oxide synthase polymorphisms with coronary artery disease in Korean individuals with or without diabetes mellitus

Experimental and Therapeutic Medicine

Volumn 1, Issue 4, 2010, Pages 719-724

  Bae, Jeehyeon ^a   Kim, In Jai ^a   Hong, Seung Ho ^b   Sung, Jung Hoon ^a   Lim, Sang Wook ^a   Cha, Dong Hoon ^a   Cho, Yong Wook ^a   Oh, Doyeun ^a   Kim, Nam Keun ^a  

^a CHA University   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

Coronary artery disease; Endothelial nitric oxide synthase; Haplotype; Polymorphism; Type 2 diabetes mellitus

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 80855143967     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000111     Document Type: Article

References (33)

1. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Rand WM, Udelson JE and Karas RH: Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 38: 1843-1849, 2001.
2. Heitzer T, Schlinzig T, Krohn K, Meinertz T and Munzel T: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104: 2673-2678, 2001.
3. Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM and Loscalzo J: American Heart Association. Atherosclerotic vascular disease conference: writing group III: pathophysiology. Circulation 109: 2617-2625, 2004.
4. Puddu P, Cravero E, Puddu GM and Muscari A: Genes and atherosclerosis: at the origin of the predisposition. Int J Clin Pract 59: 462-472, 2005.
5. Wolf A, Zalpour C, Theilmeier G, Wang BY, Ma A, Anderson B, Tsao PS and Cooke JP: Dietary l-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol 29: 479-485, 1997.
6. Kubes P, Suzuki M and Granger DN: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA88: 4651-4655, 1991.
7. Garg UC and Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
8. Böger RH, Bode-Böger SM, Mügge A, Kienke S, Brandes R, Dwenger A and Frölich JC: Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117: 273-284, 1995.
9. Hogg N, Kalyanaraman B, Joseph J, Struck A and Parthasarathy S: Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 334: 170-174, 1993.
10. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG and Marsden PA: Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 17: 2479-2488, 1997.
11. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y and Nakao K: T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99: 2864-2870, 1999.
12. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y and Nakao K: Amissense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103: 65-69, 1998.
13. Wang XL, Sim AS, Badenhop RF, McCredie R and Wilcken DE: Asmoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2: 41-45, 1996.
14. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE and Hingorani AD: Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 164: 921-935, 2006.
15. Pieper GM: Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31: 1047-1060, 1998.
16. Wilson PW: Established risk factors and coronary artery disease: the Framingham Study. Am J Hypertens 7: S7-S12, 1994.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr and Roccella EJ: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC7 report. JAMA289: 2560-2572, 2003.
18. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 27: S5-S9, 2004.
19. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, Almasy L, Badenhop RB and Wilcken DE: Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 17: 3147-3153, 1997.
20. Cooke JP: Role of nitric oxide in progression and regression of atherosclerosis: West J Med 164: 419-424, 1996.
21. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP and Moss J: Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA97: 2832-2835, 2000.
22. Kim IJ, Bae J, Lim SW, Cha DH, Cho HJ, Kim S, Yang DH, Hwang SG, Oh D and Kim NK: Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease. Thromb Res 119: 579-585, 2007.
23. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW and Hayes JR: Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 771-776, 1992.
24. Zhang C, Lopez-Ridaura R, Hunter DJ, Rifai N and Hu FB: Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among US diabetic men. Diabetes 55: 2140-2147, 2006.
25. Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Vauhkonen I and Laakso M: Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med 78: 372-379, 2000.
26. Ksiazek P, Wojewoda P, Muc K and Buraczynska M: Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus. Mol Diagn 7: 119-123, 2003.
27. Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, Valsecchi G, Lucotti P, Pozza G, Bernardinelli L, Casari G and Piatti P: Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 52: 1270-1275, 2003.
28. Rittig K, Holder K, Stock J, Tschritter O, Peter A, Stefan N, Fritsche A, Machicao F, Häring HU and Balletshofer B: Endothelial NO-synthase intron 4 polymorphism is associated with disturbed in vivo nitric oxide production in individuals prone to type 2 diabetes. Horm Metab Res 40: 13-17, 2008.
29. Lee JE, Choi JH, Lee JH and Lee MG: Gene SNPs and mutations in clinical genetic testing: haplotype-based testing and analysis. Mutat Res 573: 195-204, 2005.
30. Rios DL, Callegari-Jacques SM and Hutz MH: Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis. Clin Chim Acta 362: 138-146, 2005.
31. Rios DL, D'Onofrio LO, Souza JK, Queiroz AM, Raduy-Maron L, Silva-Neto N, Carvalho HG, Santos-Filho A and Galvão-Castro B: Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians. Atherosclerosis 193: 135-141, 2007.
32. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS and Tanus-Santos JE: Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189: 241-246, 2006.
33. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS and Tanus-Santos JE: Influence of eNOS haplotypes on the plasma nitric oxide product concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 16: 348-355, 2007.